A randomized, double-blind, multi-center study comparing the effects of carvedilol phosphate modified release formulation (Coreg-MR) with metoprolol succinate (Toprol XL) on the lipid profile in normolipidemic, or mildly dyslipidemic hypertensive patients.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Carvedilol; Metoprolol
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 07 Jun 2017 Biomarkers information updated
- 02 Feb 2010 Actual number of patients (568) and actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.